Corvela (Ranexa)500mg 100 pill Ranolaz

Corvela (Ranexa)500mg 100 pill Ranolaz

$53.84

Each Corvela contains 500 mg Ranolazine ER 100 Pills. It is used to relieve chest pain in conditions like chronic angina.

ATC Classification: C01EB18
Active Ingrediant: Ranolazine ER
Generic Name: Corvela
Manufacturer: Cipla Limited
Strength: 500mg
Dosage Type: Tablet
Packaging Type: Blister in Box
Contains: 100 Tab-ER

Description

 

Medication Safety Issues

Sound-alike/look-alike issues:

Ranexa may be confused with CeleXA, PreNexa Premier

 

Storage/Stability

Store at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F).

 

Adverse Reactions

>0.5% to 10%:

Cardiovascular: Bradycardia (≤4%), hypotension (≤4%), orthostatic hypotension (≤4%), palpitation (≤4%), peripheral edema (≤4%), prolonged QT interval on ECG (>500 msec: ≤1%)

Central nervous system: Dizziness (6%; may be dose-related), headache (≤6%), confusion (≤4%), syncope (≤4%), vertigo (≤4%)

Dermatologic: Hyperhidrosis (≤4%)

Gastrointestinal: Constipation (5%), abdominal pain (≤4%), anorexia (≤4%), dyspepsia (≤4%), nausea (≤4%; dose-related), vomiting (≤4%), xerostomia (≤4%)

Genitourinary: Hematuria (≤4%)

Neuromuscular: Weakness (≤4%)

Ophthalmic: Blurred vision (≤4%)

Otic: Tinnitus (≤4%)

Respiratory: Dyspnea (≤4%)

≤0.5%, postmarketing, and/or case reports: Angioedema, ataxia, decreased glycosylated hemoglobin, decreased T-wave amplitude, dysuria, eosinophilia, hallucination, hypoesthesia, hypoglycemia (diabetic patients), increased blood urea nitrogen, increased serum creatinine, leukopenia, pancytopenia, paresthesia, pruritus, pulmonary fibrosis, renal failure, skin rash, thrombocytopenia, torsade de pointes (Morrow 2007), tremor, T-wave changes (notched), urinary retention, urine discoloration

Brand

Cipla

Additional information

Active Ingrediant

Generic Name

Alternate Names

, , , , , , , , , ,

Strength

Dosage Type

Packaging Type

Reviews

There are no reviews yet.

Be the first to review “Corvela (Ranexa)500mg 100 pill Ranolaz”

Your email address will not be published.